Jones Day names 37 new partners
WASHINGTON, Dec. 19, 2024 /PRNewswire/ -- The global law firm Jones Day announces that the 37 lawyers listed below will be admitted to the Firm's partnership effective January 1, 2025. Jones Day names 37 new partners (presented in alphabetical...
Pharus Diagnostics LLC Announces Validation of a Laboratory-Developed Test for Early Pancreatic Cancer Detection
LOS ANGELES, Dec. 19, 2024 /PRNewswire/ -- Pharus Diagnostics LLC. (PharusDx), an innovator in non-invasive diagnostic tests, today announced a significant step forward in the fight against pancreatic cancer. The company is announcing availability...
Shengfeng Development Limited Announces Completion of the Ningde Shengfeng Smart Logistics Center, Primarily Servicing CATL
FUZHOU, China, Dec. 18, 2024 /PRNewswire/ -- Shengfeng Development Limited ("Shengfeng" or the "Company") (NASDAQ: SFWL), a contract logistics company in China providing customers with integrated logistics solutions, announced today the completion...
Boryung Announces Winners of the 3rd Humans In Space Challenge
Paving the Way as a Global Leader in Space Healthcare - Introducing of a new funding model to support space experiments and strengthen research in space healthcare - Hosted the final round of the Humans In Space Challenge at the 75th International...
Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, in Combination with Semaglutide, Demonstrated Superior Weight Loss to Semaglutide Monotherapy in a Preclinical Model
In a head-to-head diet-induced obese (DIO) mouse study, ASC47 low dose combination 1 (ASC47, 3 mg/kg, subcutaneous ( SQ ) , once every four weeks plus semaglutide, 30 nmol/kg, SQ, once daily) , demonstrated superior weight loss compared to...
Gan & Lee Pharmaceuticals Announces U.S. FDA Clearance of the IND application for the innovative Bi-weekly GLP-1RA GZR18 Injection, Bofanglutide, with chronic weight management Indication (A Phase 2 head-to-head with Tirzepatide clinical trial)
BEIJING and BRIDGEWATER, N.J., Dec. 18, 2024 /PRNewswire/ -- Gan & Lee Pharmaceuticals (Gan & Lee, Shanghai Stock Exchange: 603087.SH), is pleased to announce that the Food and Drug Administration (" FDA ") has cleared the Investigational...
Metasurface Technologies Holdings Limited Announces Strategic Partnership with Leading Semiconductor OEM
New precision-engineered components to drive next-gen semiconductor manufacturing Collaboration positions Metasurface as a key supplier for high-demand sub-180 nm wafer fab platforms SINGAPORE and HONG KONG, Dec. 18, 2024 /PRNewswire/ -- Metasurface...
Everest Medicines Announces the First Prescription of VELSIPITY® in the Greater Bay Area, Officially Benefiting Mainland China Patients
SHANGHAI, Dec. 18, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today...
Sentage Holdings Inc. Announces Financial Results for the First Six Months of Fiscal Year 2024
SHANGHAI, Dec. 18, 2024 /PRNewswire/ -- Sentage Holdings Inc. (the "Company", "we", "our") (Nasdaq: SNTG), is a holding company incorporated in the Cayman Islands with no material operations of its own. Through its China-based operating entities,...
Nisun International Announces Additional Share Repurchases Under It's $15 Million Buyback Program
SHANGHAI, Dec. 17, 2024 /PRNewswire/ -- Nisun International Enterprise Development Group Co., Ltd. ("Nisun International" or the "Company") (Nasdaq: NISN), a technology and industry driven integrated supply chain solutions provider, today announced...